The Investment Climate’s Impact on Biotechs, Tech Transfer & Pipeline
Private biotechs are operating in a fundraising environment where access to capital is limited. This has led to a spike in shutdowns, restructurings, reductions-in-force, and “strategic alternatives” across the industry...